Xencor, Inc. ( XNCR ) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma October 26, 2026 7:00 AM EDT

Company Participants

Charles Liles - Associate Director and Head of Corporate Communications & Investor Relations

Bassil Dahiyat - Co-Founder, CEO, President & Director

John Desjarlais - Executive VP of Research & Chief Scientific Officer

Jeffrey Chou - Senior Vice President of Clinical Development- Oncology

Dane Leone - Executive VP & Chief Strategy Officer

Conference Call Participants

Sumanta Kumar Pal

Steven Seedhouse - Cantor Fitzgerald & Co., Research Division

Matthew Phipps - William Blair & Company L.L.C., Research Division

Sean McCutcheon - Raymond James & Associates, Inc., Research Division

Gregory Renza - Truist Securities, Inc., Research Division

Daina Graybosch - Leerink Partners LLC, Research Division

David Nierengarten - Wedbush Securities Inc., Research Division

Sarah Medeiros - JPMorgan Chase & Co, Research Division

Derek Archila - Wells Fargo…